NDC 16729-045-01 - ATORVASTATIN CALCIUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-045
- Requested NDC
- 16729-045-01
- Package NDCs from labels
- 16729-045-10, 16729-045-15, 16729-045-01, 16729-045-16, 16729-045-17
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ATORVASTATIN CALCIUM - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-06 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-10-31 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2024-06-20 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-02-23 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - RPK Pharmaceuticals, Inc. | RPK Pharmaceuticals, Inc. | 2023-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2023-03-31 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2023-01-03 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Proficient Rx LP | Proficient Rx LP | 2022-04-01 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Quality Care Products, LLC | Quality Care Products, LLC | 2021-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2021-06-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-045-01 | ATORVASTATIN CALCIUM | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 13 | |
| 16729-045-10 | ATORVASTATIN CALCIUM | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 13 | |
| 16729-045-15 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 13 | |
| 16729-045-16 | ATORVASTATIN CALCIUM | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 13 | |
| 16729-045-17 | ATORVASTATIN CALCIUM | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 13 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-045-15 | EA - Each | 16729-045 | ec800b59-eb53-4816-ab9d-7ff42a9cb5ef | 1 | 2021-06-02 |
| 16729-045-17 | EA - Each | 16729-045 | d79f8df8-c45e-4468-97c7-9884a2fcd530 | 1 | 2018-08-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Atorvastatin calcium | ATORVASTATIN CALCIUM | Bryant Ranch Prepack | bf35034d-27ab-4263-a9ed-c7cee1a4fb0a | 2026-03-11 | Warnings, Adverse reactions | 617311 48A5M73Z4Q |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM, FILM COATED | Preferred Pharmaceuticals Inc. | a92f2742-1763-4a02-94b7-e8db714eb2f4 | 2026-03-11 | Warnings, Adverse reactions | 617310 48A5M73Z4Q |
| Atorvastatin calcium | ATORVASTATIN CALCIUM | Preferred Pharmaceuticals Inc. | 21234914-e1bb-4118-8f81-4ab4a59e9e1e | 2026-03-11 | Warnings, Adverse reactions | 617311 48A5M73Z4Q |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Direct_Rx | 0e24e7cb-1949-6686-e063-6394a90a4760 | 2026-03-06 | Warnings, Adverse reactions | 617312 |
| Atorvastatin Calcium | ATORVASTATIN CALCIUM | Direct_Rx | 124c111c-9272-eca9-e063-6394a90a0ad5 | 2026-03-05 | Warnings, Adverse reactions | 259255 48A5M73Z4Q |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | NuCare Pharmaceuticals, Inc. | 200c1994-9327-e02c-e063-6394a90a593d | 2026-03-05 | Warnings, Adverse reactions | 617311 48A5M73Z4Q |
| cle de peau BEAUTE RADIANT FLUID FOUNDATION NATURAL B50 | OCTINOXATE AND TITANIUM DIOXIDE | SHISEIDO AMERICAS CORPORATION | 4490f968-46b6-44d2-af2d-5130b52c8861 | 2026-03-05 | Warnings | 15FIX9V2JP |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | NuCare Pharmaceuticals,Inc. | c095d497-0634-6413-e053-2a95a90aa67f | 2026-03-05 | Warnings, Adverse reactions | ANDA207687 617312 48A5M73Z4Q |
| Acid Reducer Complete | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | Walgreen Company | 6f1dcfda-c12a-4c3b-80a2-c9e15517c88f | 2026-03-03 | Warnings | H0G9379FGK |
| SEYIP | CALCIUM CARBONATE | Seaip co., Ltd | d98d8626-8c42-77a5-e053-2a95a90a78e2 | 2026-03-03 | Warnings | H0G9379FGK |
| Nova Antacid | CALCIUM CARBONATE | Blueberri Inc. | 48696198-fc2b-eb24-e063-6294a90a3eae | 2026-03-02 | Warnings | H0G9379FGK |
| REGULAR STRENGTH ANTACID PEPPERMINT | CALCIUM CARBONATE | AKRON PHARMA INC | 3fb78d78-5296-4197-e063-6294a90adaae | 2026-03-02 | Warnings | H0G9379FGK |
| ATORVASTATIN CALCIUM | ATORVASTATIN CALCIUM | Bryant Ranch Prepack | d1b9e56b-1632-4450-b1ca-d8bcbba3fd7c | 2026-03-02 | Warnings, Adverse reactions | 617311 48A5M73Z4Q |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | 6OZP39ZG8H |
| TIBENA EVERY DAY REAL SUN BLOCK | TITANIUM DIOXIDE, ZINC OXIDE | KONAD CO LTD | 211c9930-4f91-cf8f-e063-6394a90a97b3 | 2026-02-26 | Warnings | 15FIX9V2JP |
| CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION MATTE M B10 | TITANIUM DIOXIDE | Shiseido Americas Corporation | 54f8210f-4934-4ada-89c3-aa89e7a09260 | 2026-02-26 | Warnings | 15FIX9V2JP |
| SHISEIDO UV PROTECTIVE COMPACT (REFILL) FAIR IVORY | OCTINOXATE, OCTOCRYLENE, AND TITANIUM DIOXIDE | SHISEIDO AMERICAS CORPORATION | c05cef12-a6a7-4682-9357-6d77f4ca3267 | 2026-02-25 | Warnings | 15FIX9V2JP |
| cle de peau BEAUTE RADIANT FOUNDATION N M I10 | OCTINOXATE AND TITANIUM DIOXIDE | Shiseido Americas Corporation | 3be1fe06-bd3b-4078-bee9-d3caf8d068ff | 2026-02-25 | Warnings | 15FIX9V2JP |
| HyVee Ultra Strength Antacid Soft Chews Cherry | CALCIUM CARBONATE | Xiamen Kang Zhongyuan Biotechnology Co., Ltd. | 4baa1398-515f-477d-e063-6394a90a4c94 | 2026-02-25 | Warnings | H0G9379FGK |
| Folartex | MULTIVITAMIN | Oncora Pharma, LLC | 0a4cb0ab-565f-45e8-a989-740bccef21cd | 2026-02-25 | Warnings, Adverse reactions | H0G9379FGK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.